NCT05830461

Brief Summary

The objective of this study is to evaluate the effectiveness of an online psychological care program to reduce anxiety, depression and negative psychological consequences and to increase a sense of coherence in the process of diagnostic evaluation and/or screening of mammary glands in women who attend a breast clinic. There will be an experimental group and a control group. The experimental group will receive the psychological intervention through a virtual platform and the control group will be given visual material with the information. This platform will be designed based on the principles of user experience (UX).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 26, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

October 19, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

7 months

First QC Date

March 21, 2023

Last Update Submit

June 29, 2023

Conditions

Keywords

Cancer Screening TestsAnxietyDepressionSense of coherencePsychological InterventionInternet-Based Intervention

Outcome Measures

Primary Outcomes (2)

  • Change in the scores of the Hospital Anxiety and Depression Scale

    This is an instrument that comprises 14 items: seven to measure anxiety and seven to measure depression experienced in the previous week. The Hospital Anxiety and Depression Scale was validated in Mexican population with a reliability of 0.81 for anxiety and 0.82 for depression. Anxiety items evaluate whether the person has been worried or has experienced sensations of fear, while depression items evaluate anhedonia or pessimistic thoughts.

    1 month, depends on when the participant finishes the modules.

  • Change in the scores of the Psychological Consequences Questionnaire

    Evaluates the negative psychological consequences of breast cancer screening. It contemplates three dimensions: Emotional Affects, Physical Affects and Social Affects.

    1 month, depends on when the participant finishes the modules.

Secondary Outcomes (1)

  • Change in the scores of the Sense of coherence

    1 month, depends on when the participant finishes the modules.

Study Arms (2)

Experimental group

EXPERIMENTAL

The experimental group will receive the self-applied intervention through a digital platform. The intervention consists of three stages, depending on the situation of the patient: 1) Patients who undergo screening and obtain negative results for malignancy, 2) patients with suspicion and undergo a biopsy, 3) Patients with positive results for breast cancer.

Behavioral: Online psychological care program to reduce psychological distress in women who attend a breast clinic

Control group

ACTIVE COMPARATOR

The experimental group will receive the self-applied intervention through written visual material that will be given to them. The content of the material will be the same as the experimental group.

Behavioral: Psychological care program to reduce psychological distress in women who attend a breast clinic

Interventions

The intervention will be online and self-applied. It will consist of 3 stages, according to the patient's situation: 1) without suspicion of cancer (A1), 2) with suspicion of cancer (A2), and 3) with confirmed diagnosis of cancer (B). Stage 1 includes modules related to the prevention and timely detection of breast cancer. Stage A2 consists of emotional management in the face of suspicion of breast cancer. In stage B, medical information about breast cancer is provided, as well as psychological strategies to face the diagnosis. Psychological techniques based on the cognitive behavioral model, mindfulness, acceptance and commitment therapy, and health beliefs are included.

Experimental group

The intervention will be delivered through printed materials. It will consist of 3 stages, according to the patient's situation: 1) without suspicion of cancer (A1), 2) with suspicion of cancer (A2), and 3) with confirmed diagnosis of cancer (B). Stage 1 includes modules related to the prevention and timely detection of breast cancer. Stage A2 consists of emotional management in the face of suspicion of breast cancer. In stage B, medical information about breast cancer is provided, as well as psychological strategies to face the diagnosis. Psychological techniques based on the cognitive behavioral model, mindfulness, acceptance and commitment therapy, and health beliefs are included.

Control group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of legal age who attend a health institution for screening studies and/or diagnostic evaluation of breast cancer.
  • Patients who can use an electronic device (smart phone, computer, laptop, tablet) to access the virtual platform.
  • Patients who give their informed consent to participate in the study.

You may not qualify if:

  • Patients with suicidal ideation and/or attempt.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Mexicano del Seguro Social

Guadalajara, Jalisco, 44300, Mexico

Location

Related Publications (15)

  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.

    PMID: 6880820BACKGROUND
  • Cockburn J, De Luise T, Hurley S, Clover K. Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography. Soc Sci Med. 1992 May;34(10):1129-34. doi: 10.1016/0277-9536(92)90286-y.

    PMID: 1641674BACKGROUND
  • Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med. 1993 Mar;36(6):725-33. doi: 10.1016/0277-9536(93)90033-z.

    PMID: 8480217BACKGROUND
  • Brandon CJ, Mullan PB. Patients' perception of care during image-guided breast biopsy in a rural community breast center: communication matters. J Cancer Educ. 2011 Mar;26(1):156-60. doi: 10.1007/s13187-010-0178-7.

    PMID: 21188664BACKGROUND
  • Castaneda SF, Malcarne VL, Foster-Fishman PG, Davidson WS, Mumman MK, Riley N, Sadler GR. Health care access and breast cancer screening among Latinas along the California-Mexican border. J Immigr Minor Health. 2014 Aug;16(4):670-81. doi: 10.1007/s10903-013-9938-x.

    PMID: 24150421BACKGROUND
  • Chujo M, Kigawa J, Okamura H. Psychological Factors and Characteristics of Recurrent Breast Cancer Patients with or without Psychosocial Group Therapy Intervention. Yonago Acta Med. 2011 Dec;54(4):65-74. Epub 2011 Dec 1.

    PMID: 24031131BACKGROUND
  • Consedine NS, Magai C, Krivoshekova YS, Ryzewicz L, Neugut AI. Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):501-10.

    PMID: 15066912BACKGROUND
  • Dominguez-Rodriguez A, Martinez-Luna SC, Hernandez Jimenez MJ, De La Rosa-Gomez A, Arenas-Landgrave P, Esquivel Santovena EE, Arzola-Sanchez C, Alvarez Silva J, Solis Nicolas AM, Colmenero Guadian AM, Ramirez-Martinez FR, Vargas ROC. A Self-Applied Multi-Component Psychological Online Intervention Based on UX, for the Prevention of Complicated Grief Disorder in the Mexican Population During the COVID-19 Outbreak: Protocol of a Randomized Clinical Trial. Front Psychol. 2021 Mar 29;12:644782. doi: 10.3389/fpsyg.2021.644782. eCollection 2021.

    PMID: 33854466BACKGROUND
  • Fang SY, Wang YL, Lu WH, Lee KT, Kuo YL, Fetzer SJ. Long-term effectiveness of an E-based survivorship care plan for breast cancer survivors: A quasi-experimental study. Patient Educ Couns. 2020 Mar;103(3):549-555. doi: 10.1016/j.pec.2019.09.012. Epub 2019 Sep 12.

    PMID: 31558323BACKGROUND
  • Galiano-Castillo N, Cantarero-Villanueva I, Fernandez-Lao C, Ariza-Garcia A, Diaz-Rodriguez L, Del-Moral-Avila R, Arroyo-Morales M. Telehealth system: A randomized controlled trial evaluating the impact of an internet-based exercise intervention on quality of life, pain, muscle strength, and fatigue in breast cancer survivors. Cancer. 2016 Oct 15;122(20):3166-3174. doi: 10.1002/cncr.30172. Epub 2016 Jun 22.

    PMID: 27332968BACKGROUND
  • Hollis C, Morriss R, Martin J, Amani S, Cotton R, Denis M, Lewis S. Technological innovations in mental healthcare: harnessing the digital revolution. Br J Psychiatry. 2015 Apr;206(4):263-5. doi: 10.1192/bjp.bp.113.142612.

    PMID: 25833865BACKGROUND
  • Holtdirk F, Mehnert A, Weiss M, Meyer B, Watzl C. Protocol for the Optimune trial: a randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors. Trials. 2020 Jan 29;21(1):117. doi: 10.1186/s13063-019-3987-y.

    PMID: 31996235BACKGROUND
  • Liao MN, Chen MF, Chen SC, Chen PL. Uncertainty and anxiety during the diagnostic period for women with suspected breast cancer. Cancer Nurs. 2008 Jul-Aug;31(4):274-83. doi: 10.1097/01.NCC.0000305744.64452.fe.

    PMID: 18600114BACKGROUND
  • Montgomery M, McCrone SH. Psychological distress associated with the diagnostic phase for suspected breast cancer: systematic review. J Adv Nurs. 2010 Nov;66(11):2372-90. doi: 10.1111/j.1365-2648.2010.05439.x.

    PMID: 21039773BACKGROUND
  • Martinez-Arriaga RJ, Dominguez-Rodriguez A, Meza-Chavolla SO, Munoz-Anacona YA, Cisneros-Hernandez AA, Gonzalez-Cantero JO, Gonzalez-Ramirez LP, Herdoiza-Arroyo PE, Ruvalcaba-Romero NA, Macias-Espinoza F, Jimenez S. "Salud Mamaria", an internet-based psychoeducational program during the breast cancer diagnosis process: Protocol for a randomized controlled trial. Contemp Clin Trials Commun. 2024 Nov 26;43:101397. doi: 10.1016/j.conctc.2024.101397. eCollection 2025 Feb.

Related Links

MeSH Terms

Conditions

Breast NeoplasmsAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Reyna J Martínez Arriaga, PhD

    University of Guadalajara

    PRINCIPAL INVESTIGATOR
  • Alejandro Domínguez Rodríguez, PhD

    University of Twente

    STUDY CHAIR
  • Sergio O Meza Chavolla, MD

    Instituto Mexicano del Seguro Social

    STUDY CHAIR
  • Fabiola Macías Espinoza, PhD

    University of Guadalajara

    STUDY CHAIR
  • Joel O González Cantero, PhD

    University of Guadalajara

    STUDY CHAIR
  • Leivy P González Ramírez, PhD

    Tecnologico de Monterrey

    STUDY CHAIR
  • Paulina Herdoiza Arroyo, PhD

    Universidad Internacional del Ecuador

    STUDY CHAIR
  • Yineth A Muñoz Anacona, BD

    University of Guadalajara

    STUDY CHAIR

Central Study Contacts

Reyna J Martínez Arriaga, PhD

CONTACT

Alejandro Domínguez Rodríguez, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patients are not aware that there is an experimental group and a control group, the participants are not related and do not know each other.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study has two arms, one is the experimental group that will receive the treatment through the online platform only, and the other is the comparison group that will receive the treatment delivered through printed visual material. The program consists of three stages that are aimed at: 1) Patients who undergo screening and obtain negative results for malignancy, 2) patients with suspicion and undergo a biopsy, 3) Patients with positive results for breast cancer.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 21, 2023

First Posted

April 26, 2023

Study Start

October 19, 2023

Primary Completion

May 1, 2024

Study Completion

August 1, 2024

Last Updated

July 3, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

The participants will be recruited in a public health institution. Since it is a government institution, one of the rules regarding the information collected is that it cannot be shared with other people or institutions outside the institution.

Locations